Detection of csgA gene in carbapenem-resistant Acinetobacter baumannii strains and targeting with Ocimum sanctum biocompounds

被引:0
|
作者
Anchana, Saishree R. [1 ]
Girija, Smiline A. S. [1 ]
Gunasekaran, Shoba [2 ]
Priyadharsini, Vijayashree J. [1 ,3 ]
机构
[1] Saveetha Univ, Dept Microbiol, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci SIMATS, PH Rd, Chennai 600077, Tamil Nadu, India
[2] DG Vaishnav Coll, Dept Biotechnol, Chennai 600106, Tamil Nadu, India
[3] Saveetha Univ, Saveetha Inst Med & Tech Sci SIMATS, Saveetha Dent Coll & Hosp, Blue Lab,BRULAC DRC, PH Rd, Chennai 600077, Tamil Nadu, India
关键词
Acinetobacter baumannii; Benzofuran; Biofilms; Drug resistance; Eugenol; Ocimum sanctum; REAL-TIME PCR; ESCHERICHIA-COLI; BIOFILM FORMATION; ESSENTIAL OILS; CURLI FIBERS; IN-VITRO; EXPRESSION; NANOPARTICLES; PREVENTION; SUBUNITS;
D O I
10.22038/IJBMS.2021.52852.11917
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective(s): Carbapenem-resistant Acinetobacter baumannii (CRAB) is considered highly virulent due to csgA gene-mediated biofilm formation. The present study aimed to target the same gene, employing the antibiofilm effect of Ocimum sanctum (O. sanctum) essential oil compounds among CRAB strains. Materials and Methods: A semi-quantitative adherent bioassay was performed to detect the biofilm formation in 73 CRAB strains. This was followed by molecular characterization, Polymerase Chain Reaction (PCR) amplification, and csgA gene sequencing. An antibiofilm assay under in vitro conditions, with essential oils of O. sanctum was performed. This was followed with further docking analysis of csgA protein with the selected compounds from the O. sanctum essential oils. A Molinspiration assessment was also done to elicit the drug likeliness of the biocompounds. Results: The biofilm assay showed 58.9% as high-grade and 31.5% as low-grade biofilm formers, while 9.58% were non-biofilm formers. Molecular characterization of the csgA gene showed 20.54% (15/73) positivity. The strains that were imipenem resistant also showed the csgA gene to be present (100%; 15/15), with 60% (9/15) and 20% (3/15) for meropenem and doripenem resistance respectively. A crystal violet assay for determining cell viability was done in vitro, which gave Minimum biofilm inhibition concentrations of 50% (MBEC50) at 25 mu l and 90% (MBEC90) at 50 mu l. The docking analysis done in silico showed benzofuran to possess the lowest binding energy and highest hydrogen bond interactions. Conclusion: The results indicate benzofuran, from the O. sanctum essential oils, to be effective in targeting the csgA gene among CRAB strains. Additionally, validation of these findings through in vivo studies is required.
引用
收藏
页码:690 / 698
页数:9
相关论文
共 50 条
  • [1] GENETIC PROFILE OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII STRAINS
    Alekseeva, A. E.
    Brusnigina, N. F.
    Makhova, M. A.
    INFEKTSIYA I IMMUNITET, 2024, 14 (04):
  • [2] The Rise of Carbapenem-Resistant Acinetobacter baumannii
    Evans, Benjamin A.
    Hamouda, Ahmed
    Amyes, Sebastian G. B.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (02) : 223 - 238
  • [3] Carbapenem-resistant Acinetobacter baumannii in the Republic of Belarus
    Gorbich, Yury
    Karpov, Igor
    Edelstein, Mikhail
    Martinovich, Alexey
    Kretchikova, Olga
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (03) : 201 - 202
  • [4] Carbapenem-resistant Acinetobacter baumannii Bacteremia in Neonates
    Nakwan, Narongsak
    Chokephaibulkit, Kulkanya
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) : 197 - 197
  • [5] Global spread of carbapenem-resistant Acinetobacter baumannii
    Higgins, Paul G.
    Dammhayn, Cathrin
    Hackel, Meredith
    Seifert, Harald
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (02) : 233 - 238
  • [6] A global view on carbapenem-resistant Acinetobacter baumannii
    Mueller, Carina
    Reuter, Sandra
    Wille, Julia
    Xanthopoulou, Kyriaki
    Stefanik, Danuta
    Grundmann, Hajo
    Higgins, Paul G.
    Seifert, Harald
    MBIO, 2023, 14 (06)
  • [7] Treating carbapenem-resistant Acinetobacter baumannii infections
    Giannella, Maddalena
    Viale, Pierluigi
    LANCET INFECTIOUS DISEASES, 2023, 23 (09): : 994 - 995
  • [8] Associations between Carbapenem Use, Carbapenem-Resistant Pseudomonas aeruginosa, and Carbapenem-Resistant Acinetobacter baumannii
    Apisarnthanarak, Anucha
    Jitpokasem, Sumana
    Mundy, Linda M.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (11): : 1235 - 1237
  • [9] Evaluation of the Efficacy of Colistin/Sulbactam Combination on Carbapenem-Resistant Acinetobacter baumannii Strains
    Cetinkol, Yeliz
    Telli, Murat
    Altuncekic Yildirim, Arzu
    Calgin, Mustafa Kerem
    MIKROBIYOLOJI BULTENI, 2016, 50 (03): : 460 - 465
  • [10] Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii
    Valenzuela, Jubelle K.
    Thomas, Lee
    Partridge, Sally R.
    van der Reijden, Tanny
    Dijkshoorn, Lenie
    Iredell, Jon
    JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) : 453 - 460